Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer for Arcutis, discusses a new virtual health platform designed to expand access pathways to roflumilast for chronic inflammatory skin diseases.
advertisement
Expanding Access to Care Through a Virtual Platform
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Recommended
Details
Overview
Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer for Arcutis, discusses a new virtual health platform designed to expand access pathways to roflumilast for chronic inflammatory skin diseases.
Title
Program Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?